Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remazolam vs midazolam sedation for bronchoscopy in mechanically ventilated ICU patients
ChiCTR2400090588Phase 4Completed
- Sponsor
- Affiliated Hospital of Chengde Medical University
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam mesylate in respiratory failure (2 arms), sponsored by Affiliated Hospital of Chengde Medical University. Primary endpoint: Sedation success rate. Started Oct 2024; status: completed.
02
Drugs
remimazolam mesylate
03
Conditions
respiratory failure
Beyond the preview
Go deeper on ChiCTR2400090588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090588.